• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精氨酸介导的“纳米炸弹”载体口服递送白藜芦醇治疗溃疡性结肠炎。

Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.

机构信息

School of Basic Medical Sciences, Xi'an Key Laboratory of Immune Related Diseases, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

出版信息

Int J Nanomedicine. 2022 Feb 9;17:603-616. doi: 10.2147/IJN.S347506. eCollection 2022.

DOI:10.2147/IJN.S347506
PMID:35177902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8843770/
Abstract

BACKGROUND

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) of unknown aetiology affecting the colon and rectum. Pterostilbene (PS) has been reported as an effective antioxidant and anti-inflammatory agent in preclinical IBD models. However, the therapeutic outcomes of PS are limited by potential side effects associated with the systemic exposure and the modest bioavailability afforded by its oral administration. These issues can be improved with the use of intelligent responsive nanoparticles with the ability of lysosome escape, given their high drug delivery capacity and reducing the side effects.

MATERIALS AND METHODS

Herein, the hyaluronic acid (HA)-modified L-arginine CO nanoparticles (HA-L-Arg-CO@NPs) loaded with PS (HA-PS@NPs) are constructed. Under lysosomal pH conditions, HA-PS@NPs liberate CO and generate a pH-activated nano-bomb effect to augment the cytosolic delivery of PS.

RESULTS

HA-L-Arg-CO@NPs show great biocompatibility and the excellent ability to target the colon. Using lipopolysaccharide-induced inflammation in vitro, the prominent anti-inflammatory effect of HA-L-Arg-CO@NPs and HA-PS@NPs is observed. Further, orally administered HA-L-Arg-CO@NPs and HA-PS@NPs via the colon-targeted chitosan/alginate (CA) hydrogel downregulate pro-inflammatory cytokines and reduce intestinal permeability, yielding significant outcomes in alleviating the symptoms of UC.

CONCLUSION

This pH-activated "nano-bomb" carrier with therapeutic effect can be exploited as efficient oral drug carriers for UC treatment.

摘要

背景

溃疡性结肠炎(UC)是一种病因不明的慢性炎症性肠病(IBD),影响结肠和直肠。研究表明,白藜芦醇(PS)在临床前 IBD 模型中是一种有效的抗氧化和抗炎剂。然而,PS 的治疗效果受到其全身暴露相关的潜在副作用和口服给药时适度的生物利用度的限制。这些问题可以通过使用具有溶酶体逃逸能力的智能响应纳米粒子来改善,因为它们具有高药物递送能力并减少副作用。

材料和方法

本文构建了透明质酸(HA)修饰的 L-精氨酸 CO 纳米粒子(HA-L-Arg-CO@NPs)负载 PS(HA-PS@NPs)。在溶酶体 pH 条件下,HA-PS@NPs 释放 CO 并产生 pH 激活的纳米炸弹效应,增强 PS 的细胞内递送。

结果

HA-L-Arg-CO@NPs 表现出良好的生物相容性和靶向结肠的优异能力。通过体外脂多糖诱导的炎症,观察到 HA-L-Arg-CO@NPs 和 HA-PS@NPs 的显著抗炎作用。此外,通过结肠靶向壳聚糖/海藻酸钠(CA)水凝胶口服给予 HA-L-Arg-CO@NPs 和 HA-PS@NPs,下调促炎细胞因子并降低肠道通透性,对缓解 UC 症状有显著效果。

结论

这种具有治疗作用的 pH 激活“纳米炸弹”载体可用作治疗 UC 的有效口服药物载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/d99de499fe55/IJN-17-603-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/a166df2c19d2/IJN-17-603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/a6c8026308d3/IJN-17-603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/af7e825b343b/IJN-17-603-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/5ec8bc05341d/IJN-17-603-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/c0b3b3b9ae22/IJN-17-603-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/ff69ae830267/IJN-17-603-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/d99de499fe55/IJN-17-603-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/a166df2c19d2/IJN-17-603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/a6c8026308d3/IJN-17-603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/af7e825b343b/IJN-17-603-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/5ec8bc05341d/IJN-17-603-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/c0b3b3b9ae22/IJN-17-603-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/ff69ae830267/IJN-17-603-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf7/8843770/d99de499fe55/IJN-17-603-g0007.jpg

相似文献

1
Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.精氨酸介导的“纳米炸弹”载体口服递送白藜芦醇治疗溃疡性结肠炎。
Int J Nanomedicine. 2022 Feb 9;17:603-616. doi: 10.2147/IJN.S347506. eCollection 2022.
2
An oral pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis.一种口服 pH 激活的“纳米炸弹”载体,通过调节基因沉默和肠道微生物群联合小檗碱,用于溃疡性结肠炎的靶向治疗。
Biomater Sci. 2022 Feb 15;10(4):1053-1067. doi: 10.1039/d1bm01765a.
3
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.通过透明质酸功能化纳米颗粒口服靶向递送三肽KPV可有效缓解溃疡性结肠炎。
Mol Ther. 2017 Jul 5;25(7):1628-1640. doi: 10.1016/j.ymthe.2016.11.020. Epub 2017 Jan 28.
4
Oral bomb effect nanotherapeutics alleviate ulcerative colitis through coordinated anti-inflammatory and pro-resolving strategies.口服炸弹效应纳米治疗通过协调抗炎和促解决策略缓解溃疡性结肠炎。
Biomater Sci. 2024 Oct 8;12(20):5386-5403. doi: 10.1039/d4bm00843j.
5
Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.姜辣素 6-姜烯酚载药纳米粒子经口给药减轻溃疡性结肠炎小鼠模型的炎症并促进其创面愈合。
J Crohns Colitis. 2018 Jan 24;12(2):217-229. doi: 10.1093/ecco-jcc/jjx115.
6
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.盐酸小檗碱载黏液穿透性海藻酸钠-壳聚糖纳米粒口服递送至溃疡性结肠炎炎症部位。
AAPS PharmSciTech. 2022 Jun 27;23(6):179. doi: 10.1208/s12249-022-02327-4.
7
Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.载姜黄素的果胶酸钙和透明质酸修饰乳铁蛋白纳米粒的双重靶向治疗溃疡性结肠炎。
Carbohydr Polym. 2021 Jul 1;263:117998. doi: 10.1016/j.carbpol.2021.117998. Epub 2021 Mar 27.
8
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.溃疡性结肠炎的联合治疗:口服靶向纳米颗粒预防黏膜损伤并减轻炎症。
Theranostics. 2016 Sep 25;6(12):2250-2266. doi: 10.7150/thno.15710. eCollection 2016.
9
Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.透明质酸修饰的具有黏附性和巨噬细胞靶向性的口服药物传递系统,用于治疗结肠炎。
Carbohydr Polym. 2023 Aug 1;313:120884. doi: 10.1016/j.carbpol.2023.120884. Epub 2023 Apr 11.
10
Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.溃疡性结肠炎治疗的口服药物传递系统:微球和纳米粒的比较研究。
Curr Cancer Drug Targets. 2019;19(4):304-311. doi: 10.2174/1568009618666181016152042.

引用本文的文献

1
A targeted and synergetic nano-delivery system against infection for promoting wound healing.一种用于抗感染以促进伤口愈合的靶向协同纳米递送系统。
Mater Today Bio. 2025 Jan 9;31:101470. doi: 10.1016/j.mtbio.2025.101470. eCollection 2025 Apr.
2
Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics.认识胃肠道的生物学屏障和病理生理学特征,用于设计和应用纳米药物。
Drug Deliv. 2024 Dec;31(1):2415580. doi: 10.1080/10717544.2024.2415580. Epub 2024 Oct 15.
3
Dual-Sensitive Carbohydrate-Based Nanosystem for Targeted Drug Delivery to Potentiate the Therapeutic Efficacy of Ulcerative Colitis.

本文引用的文献

1
Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease.纳米医学介导的治疗在炎症性肠病中的当前策略和潜在前景。
Int J Nanomedicine. 2021 Jun 23;16:4225-4237. doi: 10.2147/IJN.S310952. eCollection 2021.
2
Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD.药物递送至炎症性肠黏膜 - 靶向技术和人类细胞培养模型,以改善 IBD 的治疗效果。
Adv Drug Deliv Rev. 2021 Aug;175:113828. doi: 10.1016/j.addr.2021.113828. Epub 2021 Jun 19.
3
Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway.
双敏感基于碳水化合物的纳米系统用于靶向药物输送,以增强溃疡性结肠炎的治疗效果。
Int J Nanomedicine. 2024 Aug 21;19:8555-8572. doi: 10.2147/IJN.S472244. eCollection 2024.
4
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.靶向肠道:特定药物纳米载体的系统评价
Pharmaceutics. 2024 Mar 21;16(3):431. doi: 10.3390/pharmaceutics16030431.
5
Pterostilbene: a potential therapeutic agent for fibrotic diseases.紫檀芪:一种潜在的抗纤维化疾病治疗剂。
Inflammopharmacology. 2024 Apr;32(2):975-989. doi: 10.1007/s10787-024-01440-z. Epub 2024 Mar 1.
6
Oral Administration of Platinum Nanoparticles with SOD/CAT Cascade Catalytic Activity to Alleviate Ulcerative Colitis.口服具有超氧化物歧化酶/过氧化氢酶级联催化活性的铂纳米颗粒以缓解溃疡性结肠炎
J Funct Biomater. 2023 Nov 15;14(11):548. doi: 10.3390/jfb14110548.
7
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.口服氧化铈纳米酶用于炎症性肠病的 CT 成像及抗炎/抗纤维化治疗。
J Nanobiotechnology. 2023 Jan 19;21(1):21. doi: 10.1186/s12951-023-01770-0.
8
Increased brain uptake of pterostilbene loaded folate modified micellar delivery system.载白藜芦醇的叶酸修饰胶束递药系统增加脑部摄取。
Drug Deliv. 2022 Dec;29(1):3071-3086. doi: 10.1080/10717544.2022.2126559.
紫檀芪通过抑制NF-κB介导的肌球蛋白轻链激酶-肌球蛋白轻链信号通路改善右旋糖酐硫酸钠诱导的小鼠肠道上皮屏障损伤。
J Agric Food Chem. 2021 Apr 7;69(13):3871-3878. doi: 10.1021/acs.jafc.1c00274. Epub 2021 Mar 24.
4
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
5
Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development.紫檀芪通过抑制树突状细胞的激活和促进调节性 T 细胞的发育来减轻结肠炎症。
FASEB J. 2020 Nov;34(11):14810-14819. doi: 10.1096/fj.202001502R. Epub 2020 Sep 22.
6
Arginase impedes the resolution of colitis by altering the microbiome and metabolome.精氨酸酶通过改变微生物组和代谢组来阻碍结肠炎的缓解。
J Clin Invest. 2020 Nov 2;130(11):5703-5720. doi: 10.1172/JCI126923.
7
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.载姜黄素纳米结构脂质载体增强溃疡性结肠炎的治疗作用。
Int J Nanomedicine. 2020 Jun 3;15:3937-3951. doi: 10.2147/IJN.S247406. eCollection 2020.
8
Paeoniflorin ameliorates ulcerative colitis by modulating the dendritic cell-mediated T17/T balance.芍药苷通过调节树突状细胞介导的 T17/T 平衡改善溃疡性结肠炎。
Inflammopharmacology. 2020 Dec;28(6):1705-1716. doi: 10.1007/s10787-020-00722-6. Epub 2020 May 29.
9
Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings.转录组学和代谢组学分析在炎症性肠病中的 L-精氨酸/一氧化氮通路及其与局部炎症和血管生成反应的关系:初步发现。
Int J Mol Sci. 2020 Feb 28;21(5):1641. doi: 10.3390/ijms21051641.
10
A Novel Strategy for Treating Inflammatory Bowel Disease by Targeting Delivery of Methotrexate through Glucan Particles.一种通过葡聚糖颗粒靶向递送甲氨蝶呤治疗炎症性肠病的新策略。
Adv Healthc Mater. 2020 Mar;9(6):e1901805. doi: 10.1002/adhm.201901805. Epub 2020 Feb 24.